{"classes":[{"categories":[{"measurements":[{"groupId":"OG000","lowerLimit":"6.5","upperLimit":"11.2","value":"8"}]}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"45"}],"units":"Participants"}],"description":"Duration of response defined as the time between achieving response and progression of disease.","dispersionType":"Full Range","groups":[{"description":"All evaluable participants","id":"OG000","title":"Evaluable Participants"}],"paramType":"MEDIAN","populationDescription":"45 participants were evaluable for response.","reportingStatus":"POSTED","timeFrame":"Up to 24 months","title":"Phase 2: Duration of Response","type":"SECONDARY","unitOfMeasure":"months"}